Clinical Trial Update: Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot [NA]

View source ↗

Summary

A pilot trial (OPTIMAL) evaluating outpatient platelet transfusions in patients with myelodysplastic syndromes and leukemia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndrome

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Myelodysplastic Syndrome, Leukemia | NA | Status: TERMINATED